C3 anticorps (HRP)
Aperçu rapide pour C3 anticorps (HRP) (ABIN113306)
Antigène
Voir toutes C3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- This antibody detects Complement 3c, a polypeptide fragment which is present in C3.
-
Purification
- Affinity chromatography on Protein G.
-
Immunogène
- Complement 3c.
-
-
-
-
Indications d'application
-
Suitable for ELISA (1/200-1/800) and Western blotting (1/500-1/2000).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS, pH 7.2, containing 0.01 % Thiomersal as preservative.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store lyophilized product at 2 - 8 °C. Following reconstitution store at -20 °C.
-
-
- C3 (Complement Component 3 (C3))
-
Autre désignation
- Complement C3
-
Sujet
- C3 plays a central role in the activation of the complement system. Processing of C3 by C3 convertase is the central reaction in both classical and alternative complement pathways, resulting in C3a and C3b. C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates, and help to initiate the complement cascade, potentially resulting in cellular apoptosis. C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C3b is rapidly split in two positions by factor I and a cofactor to form iC3b (inactivated C3b) and C3f which is released. Then iC3b is slowly cleaved (possibly by factor I) to form C3c and C3dg. Defects in C3 can result in susceptibility to pyogenic infection.Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CPAMD1, Complement component 3
-
ID gène
- 718
-
NCBI Accession
- NP_000055
-
UniProt
- P01024
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-